Floating drug delivery system is one of the novel drug delivery system. Floating drug delivery system have a bulk density less than gastric fluids and thus it remains buoyant in the stomach without affecting gastric emptying rate for a prolonged period of time. Verapamil HCL is calcium channel blocker drug with short elimination half-life 2.8-7.4 hours Floating microspheres of Verapamil HCL were prepared by Emulsion solvent evaporation method by using HPMC K4M, HPMC K15M and Ethyl cellulose as polymers. The floating microspheres were evaluated for micromeritic properties, particle size, percentage yield, invitro buoyancy, incorporation efficiency and in-vitro drug release. Results show that as the concentration of polymer increases it affects the particle size, percentage yield, in-vitro buoyancy and in-vitro drug release of microspheres. The micromeritic property was found to be good and scanning electron microscopy confirmed their hollow structure with smooth surface. Formulation F5 ( drug : EC 1:2) prepared with Ethyl cellulose exhibited excellent micromeritic properties, percentage yield, in vitro buoyancy, incorporation efficiency and percentage drug release 99.86% for a period of 12 hrs. The data obtained in this study thus suggest that floating microspheres of Verapamil HCL are promising for sustained drug delivery, which can reduce dosing frequency.
INTRODUCTION
Recent scientific and patent literature shows increased interest in academics and industrial research groups regarding the novel dosage forms that can be retained in the stomach for a prolonged and predictable period of time. One of the most feasible approaches for achieving a prolonged and predictable drug delivery profile in the GI tract is to control the gastric residence time (GRT), using gastroretentive drug delivery system (GRDDS) that will provide us with new and important therapeutic options. Gastroretentive system can remain in the gastric region for several hours and hence significantly prolong the gastric residence time of drugs 1 . Prolonged gastric retention improves bioavailability, reduces drug waste, and improves solubility of drugs that are less soluble in a high pH environment. It has applications also for local drug delivery to the stomach and proximal small intestines. Gastro retention helps to provide better availability of new products with new therapeutic possibilities and substantial benefits for patients 2, 3 .
Floating microspheres are gastro-retentive drug delivery systems based on non-effervescent approach. Hollow microspheres are in strict sense, spherical empty particles without core. These microspheres are characteristically free flowing powders consisting of proteins or synthetic polymers, ideally having a size less than 200 micrometer 4 . Solid biodegradable microspheres incorporating a drug dispersed or dissolved throughout particle matrix have the potential for controlled release of drugs. The floating microspheres have been utilized to obtain prolonged and uniform release in the stomach for development of a once daily formulation. When microspheres come in contact with gastric fluid the gel formers, polysaccharides, and polymers hydrate to form a colloidal gel barrier that controls the rate of fluid penetration into the device and consequent drug release. As the exterior surface of the dosage form dissolves, the gel layer is maintained by the hydration of the adjacent hydrocolloid layer. The air trapped by the swollen polymer lowers the density and confers buoyancy to the microspheres. However a minimal gastric content needed to allow proper achievement of buoyancy 5, 6 .
Verapamil HCL is a calcium channel blocker that is a class IV antiarrhythmia agent, inhibits voltage-dependent calcium channels. Specifically, its effect on L-type calcium channels in the heart causes a reduction in ionotropy and chronotropy, thus reducing heart rate and blood pressure and its half life is 2.8 to 7.4 hours 7 .
The aim of present work is to develop the floating microspheres of Verapamil HCL by emulsion solvent evaporation method. Verapamil HCL whose physiochemical properties and short half-life make it suitable candidate for floating drug delivery system.
MATERIALS AND METHODS
Verapamil was obtained from SURA labs Hyderabad. Ethyl cellulose, HPMC K4 M and HPMC K15M were purchased from Merk specialiities Pvt Limited, Mumbai.
Fourier transform infrared spectroscopy (FT-IR)
In order to check the integrity (Compatibility) of drug in the formulation, FT-IR spectra of the formulations along with the drug and other excipients were obtained and compared using Shimadzu FT-IR 8400 spectrophotometer. In the present study, Potassium bromide(KBr) pellet method was employed. The samples were thoroughly blended with dry powdered potassium bromide crystals. The mixture was compressed to form a disc. The disc was placed in the spectrophotometer and the spectra was recorded.The FTIR spectra of the formulations were compared with the FT-IR spectra of the pure drug and the polymers.
Method of preparation Emulsion solvent evaporation
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The floating microspheres of verapamil HCL were prepared by emulsion solvent evaporation method using different polymers as follows:
The drug and polymer (HPMC K4M, Ethyl cellulose, HPMC K15M) in different proportions are weighed as per the requirements given in the table-1. The polymer was co dissolved into previously cooled mixture of ethanol: dichloromethane at room temperature. The mixture was stir vigorously to form uniform drug polymer dispersion. The above organic phase was slowly added to 100 ml distilled water containing 0.1% tween 80 by maintain the temperature at 15 -20°C and emulsified by stirring at 500 rpm for 30 min. microspheres formed were filtered, washed with water and sieved between 50 and 30 mesh size, and dried overnight for 40°Cand then air-dried.
CHARACTERIZATION OF MICROSPHERES Percentage Yield
The percentage of production yield was calculated from the weight of dried microspheres recovered from each batch and the sum of initial weight if starting materials. The percentage yield was calculated using the following formula
Drug entrapment efficiency
Microspheres equivalent to 100 mg of the drug Verapamil HCL were taken for evaluation. The amount of drug entrapped was estimated by crushing the microspheres. The powder was transferred to a 100 ml volumetric flask and dissolved in 10ml of methanol and the volume was made up using simulated gastric fluid pH 1.2. After 24 hours the solution was filtered through Whatmann filter paper and the absorbance was measured after suitable dilution spectrophotometrically at 235 nm 11 . The amount of drug entrapped in the microspheres was calculated by the following formula
Micromeritic properties
The microspheres were characterized by their micromeritic properties such as particle size, bulk density, tapped density, compressibility index, Hausner's ratio and angle of repose 12 .
Bulk density
In this method floating microspheres are transferred to a measuring cylinder and is tapped manually till a constant volume is obtained. This volume is bulk volume and it includes true volume of the powder and the void space among the microspheres.
Tapped density
In this method floating microspheres were transferred to a measuring cylinder & tapped for 100 times. After tapping volume of microspheres was visually examined. The ratio of mass of microspheres to volume of microspheres after tapping gives tapped density floating microspheres. Percent Compressibility index was determined by using the formula,
Hausner's ratio
Hausner's ratio of microspheres was determined by comparing tapped density to bulk density using the equation
Angle of repose
Angle of repose (θ) of the microspheres, which measures the resistance to particle flow, was determined by a fixed funnel method4. The height of the funnel was adjusted in such a way that the tip of the funnel just touches the heap of the blends. Accurately weighed microspheres were allowed to pass through the funnel freely on to the surface. The height and radius of the powder cone was measured and angle of repose was calculated using the following equation. 
Particle size analysis
Samples of the microparticles were analyzed for particle size by optical microscope. The instrument was calibrated and found that 1unit of eyepiece micrometer was equal to 10 μm. Nearly about 100 Microparticles sizes were calculated under 45 x magnifications. The average particle size was determined by using the Edmondson's equation.
Where , n -Number of microspheres observed, d -Mean size range
In-vitro Buoyancy
Floating microspheres (equivalent to 100 mg) were dispersed in 900ml of 0.1 N hydrochloric acid solution (pH 1.2) to simulate gastric fluid at 37°. The mixture was stirred with a paddle at 75 rpm and after 12 hr, the layer of buoyant microspheres (Wf) was pipetted and separated by filtration simultaneously sinking microsphere (Ws) was also separated. Both microspheres type were dried at 40°C overnight. Each weight was measured and buoyancy was determined by the weight ratio of the floating microspheres to the sum of floating and sinking microsphere 13 .
Where Wf and Ws were the weights of the floating and settled microspheres, respectively. All the determinations were made in triplicate.
In-vitro drug release study
The dissolution studies were performed in a fully calibrated eight station dissolution test apparatus (37 ± 0.5°C, 75 rpm) using the USP type -I rotating basket method in simulated gastric fluid pH 1.2 (900ml). A quantity of accurately weighed microspheres equivalent to 100 mg Verapamil HCL each formulation was employed in all dissolution studies. Aliquots of sample were withdrawn at predetermined intervals of time and analyzed for drug release by measuring the absorbance at 235 nm. At the same time the volume withdrawn at each time intervals were replenished immediately with the same volume of fresh pre-warmed simulated gastric fluid pH 1.2 maintaining sink conditions throughout the experiment 14 .
Release kinetics
To study the release kinetics, data obtained from in-vitro drug release study was tested with the Zero order equation, First order equation, Higuchi square root law and Korsmeyer-Peppas equation 15 . Zero order equation assumes that the cumulative amount of drug release is directly related to time. The equation may be as follows:
C=k0t
Where, k0 is the zero order rate constant expressed in unit concentration/time and t is the time in hour. A graph of concentration vs time would yield a straight line with a slope equal to k0 and intercept the origin of the axes.
The release behaviour of first order equation is expressed as log cumulative percentage of drug remaining vs time. The equation may be as follows. If n≤0.5, the release mechanism follows a Fickian diffusion, and if 0.5<n<1, the release follows non-Fickian diffusion or anomalous transport. The drug release follows zero order and case II transport if n=1. But when n>1, then the release mechanism is super case II transport. This model is used in the polymeric dosage form when the release mechanism is unknown or more than one release phenomenon is present in the preparation.
RESULTS AND DISCUSSION
Compatibility studies by FTIR
The FTIR spectra of pure drug and drug along with excipients have been obtained. There was no appearance or disappearance of any characteristics peaks. This shows that there is no chemical interaction between the drug and the polymers used. The data was shown in Figure 1 -5.
Micrometric properties
The mean size increased with increasing polymer concentration which is due to a significant increase in the viscosity, thus leading to an increased droplet size and finally a higher microspheres size. 
Yield of floating microspheres
The percentage of yield of floating microsphere formulations was in the range of 77.84±0.64% to 93.78±0.55%.At low concentration of HPMC, part of polymer solution aggregated in a fibrous structure, as it solidified prior to forming droplets or the transient droplets were broken before solidification was complete due to poor mechanical strength resulting into low yield. The results are given in the table-3.
In-vitro Buoyancy
The purpose of preparing floating microspheres was to extend the gastric residence time of a drug. The buoyancy test was carried out to investigate the floatability of the prepared microspheres. The invitro buoyancy time for the formulations was more than 12 hours in the simulated gastric fluid.
Incorporation efficiency (%)
The incorporation efficiency of all the formulations was found to be in the range of 77.43±2.72% to 98.11±2.59%. Among all the formulations, formulation F5 has shown maximum entrapment efficiency which demonstrated that increase in ethylcellulose concentration causes increase in entrapment of the drug. The entrapment efficiency was good in all the formulations and is mentioned in the table-3.
In-Vitro drug release
The results of in-vitro drug release have been represented in the This shows that more drug release was observed with the increase in percentage of polymers. As the polymer to drug ratio was increased the extant of drug release decreased. A significant decrease in the rate and extant of drug release is attributed to the increase in density of polymer matrix that results in increased diffusion path length which the drug molecules have to traverse. The release of the drug has been controlled by swelling mechanism. Additionally, the larger particle size at higher polymer concentration also restricted the total surface area resulting in slower release.
From various formulations developed formulation F5 is considered to be the best with desired drug release for 12 hours and maximum incorporation efficiency when compared to other formulations.
Release kinetics
Various release kinetic models have been explored to understand the mechanism of drug release form the developed formulations. The best fit model for various formulations has been represented in the table-5. The mechanism of drug release from the optimized formulation is by peppas model and the drug release followed a combination of diffusion and erosion mechanisms. 
CONCLUSION
Floating microspheres of Verapamil HCL were successfully prepared by using HPMC and Ethyl cellulose as polymers by emulsion solvent evaporation. The flow properties of all the prepared microspheres were good as indicated by low angle of repose and low compressibility index. The good flow properties suggested that the microspheres produced were nonaggregated. The mean particle size of microspheres was in the range of 102.33-420.53 µm depending upon the type of polymer used. The particle size increased significantly as the amount of polymer increased. The percent yield of all floating microspheres formulation was more than 60% suggesting that the methods used for encapsulation was effective. The percent yield was significantly increased as the amount of polymer was increased in each preparation method. The entrapment efficiency was good in all the cases. This suggested that optimized parameters were used in the method of preparations. The in-vitro buoyancy was more than 70% after 12 hours indicated satisfactory performance of proposed formulations. The percent buoyancy increased significantly as the amount of polymer was increased in each preparation method. In-vitro release of floating microspheres ofVerapamil HCL was found to be in following order. F5>F3>F7>F8>F6> F9>F4>F2>F1. Among all formulations, F5 was found to be the best formulation as it release Verapamil HCL 98.65 % in a controlled manner with constant fashion over extended period of time (up to 12 hrs). In vitro release data fitted into various kinetic models suggest that the release obeyed mixed order kinetic, Zero order mechanism and non fickian control (anomalous diffusion) with swelling.
Hence, finally it was concluded that the prepared floating microspheres of Verapamil HCL may prove to be potential candidate for safe and effective controlled drug delivery over an extended period of time which can reduce dosing frequency.
